Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acids and salts thereof
Reexamination Certificate
2007-08-07
2010-06-08
Kumar, Shailendra (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acids and salts thereof
C554S063000, C514S563000, C514S625000
Reexamination Certificate
active
07732637
ABSTRACT:
The present invention provides an acylamide compound of the following formula (1), prodrugs thereof, or pharmaceutically acceptable salts thereof; and an adiponectin inducer or secretagogue, therapeutic agent of metabolic syndromes, therapeutic agent of hypoadiponectinemia, therapeutic agent of hyperlipemia, preventive/therapeutic agent of diabetes, improving agent of impaired glucose tolerance, improving agent of insulin resistance, enhancing agent of insulin sensitivity, therapeutic agent of hypertension, preventive/therapeutic agent of vascular disorders, an anti-inflammatory agent, therapeutic agent of hepatic inflammation, therapeutic agent of fatty liver, therapeutic agent of hepatic fibrosis, therapeutic agent of liver cirrhosis, preventive/therapeutic agent of non-alcoholic
onviral steatohepatitis (NASH) or non-alcoholic
onviral fatty liver disease (NAFLD), or therapeutic agent of obesity, each of which has the above compounds as an active ingredient.
REFERENCES:
patent: 5266576 (1993-11-01), Vincent et al.
patent: 6090250 (2000-07-01), Mazzeo et al.
patent: 6335468 (2002-01-01), Hatajima et al.
patent: 29-6713 (1954-10-01), None
patent: 05-132454 (1993-05-01), None
patent: 9-503295 (1997-03-01), None
patent: 2001-187769 (2001-07-01), None
Philipp E. Scherer, et al., “A Novel Serum Protein Similar to C1q. Produced Exclusively in Adipocytes”, The Journal of Biological Chemistry, vol. 270, 45 Issue of Nov. 10, pp. 26746-26749, 1995.
Erding Hu, et al., “Adipoq is a Novel Adipose-Specific Gene Dysregulated in Obesity”, The Journal of Biological Chemistry, vol. 271, No. 18, Issue of May 3, p. 10697-10703, 1996.
Makoto Daimon, et al., “Decreased Serum Levels of Adiponectin are a Risk Factor for the Progression to Type 2 Diabetes in the Japanese Population”, Epidemiology/ Health Services/Psychosocial Research, Diabetes Care, vol. 26, No. 7, Jul. 2003.
T. Yamauchi, et al., “The Fat-Derived Hormone Adiponectin Reverses Insulin Resistance Associated With Both Lipoatrophy and Obesity”, Nature Medicine. vol. 7, No. 8, Aug. 2001, pp. 941-946.
Anders H. Berg, et al., “The Adipocyte-Secreted Protein ACRP 30 Enhances Hepatic Insulin Action” Nature Medicine, vol. 7, No. 8, Aug. 2001, pp. 947-953.
Yoshihisa Okamoto, et al., “Circulation” American Heart Association, Learn and Live, Journal of the American Heart Association, Downloaded from Circ.ahajournals.org at Ajinomoto Co Inc on Apr. 30, 2007.
Yoshihiro Kamada, et al., “Basic-Liver, Pancreas, and Biliary Tract”, Gastroenterology 2003, 125, pp. 1796-1807.
Takayuki Masaki, et al., “Adiponectin Protects LPS-Induced Liver Injury Through Modulation of TNF-α in KK-Ay Obese Mice”, Hepatology, vol. 40, No. 1, 2004, pp. 117-184.
E. Jungermann, et al., “The Preparation of Long Chain N-Acylamino Acids”, vol. 78, pp. 172-174.
Uzi Beitler, et al., “Interaction Between Asymmetric Solutes and Solvents Diamides Derived From L-Valine as Stationary Phases in Gas-Liquid Partition Chromatography”, Journal of chromatography, 123 (1976), pp. 149-166.
R. Charles, et al., “Separation of Enantiomers on Packed Columns Containing Optically Active Diamide Phases”; Journal of Chromatography, 112 (1975), pp. 121-133.
Fukuchi Naoyuki
Hatanaka Toshihiro
Ikehara Osamu
Ishida Nozomu
Kawato Yayoi
Ajinomoto Co. Inc.
Kumar Shailendra
Oblon, Spivak McClelland, Maier & Neustadt, L.L.P.
LandOfFree
Acylamide compounds having secretagogue or inducer activity... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acylamide compounds having secretagogue or inducer activity..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acylamide compounds having secretagogue or inducer activity... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4199050